Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody

Abstract Acute myeloid leukemia (AML) remains a therapeutic challenge despite recent therapeutic advances. Although monoclonal antibodies (mAbs) engaging natural killer (NK) cells via antibody-dependent cellular cytotoxicity (ADCC) hold promise in cancer therapy, almost none have received clinical a...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Sylwia A. Stefańczyk, Ilona Hagelstein, Martina S. Lutz, Stefanie Müller, Samuel J. Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S. Heitmann, Helmut R. Salih, Melanie Märklin
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Publishing Group 2024-04-01
Serier:	Blood Cancer Journal
Online adgang:	https://doi.org/10.1038/s41408-024-01050-6
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!